End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 THB | -1.82% |
|
+1.89% | +20.67% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm trades with high earnings multiples: 27 times its 2024 earnings per share.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.67% | 795M | - | ||
-34.77% | 13.2B | B+ | ||
+4.48% | 11.76B | B+ | ||
-3.60% | 11.57B | B | ||
+8.44% | 10.67B | B+ | ||
+28.58% | 8.64B | B | ||
-9.79% | 7.24B | A- | ||
+10.23% | 6.98B | B- | ||
+8.59% | 6.46B | D | ||
0.00% | 4.99B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VIBHA Stock
- Ratings Vibhavadi Medical Center